This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Pneumonia or Laboratory Confirmed Influenza
and you are
between 6 and 23
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Pneumonia is the leading cause of child death worldwide. Data from Bangladesh indicates that influenza has a substantial association with pneumonia among children less than two years old. This study will use commercially available trivalent inactivated vaccine (killed vaccine) to see if it can prevent early childhood pneumonia among children less than two years old. The study will vaccinate children across three seasons (3 years), and look at the effect on the attack rate of pneumonia, as well as its effects on laboratory-confirmed influenza. It will also look at the effect on laboratory-confirmed influenza illness among the non-vaccinated household contacts of all ages of these children.

Provided treatments

  • Biological: Trivalent inactivated influenza vaccine

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01319955. The sponsor of the trial is International Centre for Diarrhoeal Disease Research, Bangladesh and it is looking for 3508 volunteers for the current phase.
Official trial title:
Influenza Vaccine Efficacy Against Childhood Pneumonia in an Urban Tropical Setting